Evidence-based Management of Stroke

個数:

Evidence-based Management of Stroke

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 344 p.
  • 言語 ENG
  • 商品コード 9781903378762
  • DDC分類 616.81

Full Description

Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.

Contents

Foreword; Thrombolysis in ischemic stroke; Management of stroke risk factors; Antithrombotic therapies in stroke prevention; Anticoagulant therapy in prevention of ischemic stroke; Interventions for acute ischemic stroke; Interventions for carotid artery disease & intracranial stenosis; Surgery for acute ischemic stroke; Management of ruptured cerebral aneurysms & aneurysmal subarachnoid hemorrhage; Management of spontaneous intracerebral hemorrhage; Cerebral venous sinus thrombosis; Ischemic stroke in children; Stroke in pregnancy & puerperium; Oral contraceptives, hormonal therapy & stroke; The management of cerebrovascular complications in cardiac procedures; Central nervous system vascular malformations; Index.

最近チェックした商品